Reference Group: Clinical Trials

8 trials of Reference Group, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 enrolling by invitation, 1 not yet recruiting, 1 terminated. 5 Not applicable, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 4, Terminated 1
Phase 11Not yet recruiting 1
Phase 31Completed 1

Follow Reference Group: new trials by email Literature Review of Reference Group trials Research Report on Reference Group

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bioequivalence Study of Fluvastatin Sodium Extended Release Tablets in Healthy Participants
Group A, Reference Group - Bioequivalence
Phase 1Not yet recruitingShenzhen Salubris Pharmaceuticals Co., Ltd.1102025-02-012025-02-17
Domperidone on the Composition of Preterm Breastmilk Using a Human Milk Mid-infrared Spectroscopy Analyzer
Test group, Reference group - Insufficient Breast Milk Syndrome, Premature Birth
Enrolling by invitationCentro Hospitalar de Lisboa Central812025-01-082025-03-18
Growth and Tolerance of Infants Fed Milk-Based Infant Formula
Control Infant Formula, Experimental Infant Formula, Reference Group - Gastro-Intestinal Tolerance
Not applicableCompletedAbbott Nutrition1892019-06-082020-09-22
Effect of a Prebiotic on Colic and Crying and Fussing Behaviour in Infants
Experimental Infant formula, Reference group - Colic
Not applicableTerminatedMcMaster University12017-12-132019-08-28
Pilot Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients Patients
Investigational Group, Reference group - Vital Sign Monitoring
Not applicableCompletedDarma Inc.152017-09-012019-04-16
Pilot Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients
Investigational Group, reference group - Vital Sign Monitoring
Not applicableCompletedDarma Inc.152017-08-022019-04-16
Gastrointestinal Tolerance of Infant Formula
Experimental 1 Infant Formula, Experimental 2 Infant Formula, Reference Group - Gastrointestinal Tolerance
Not applicableCompletedAbbott Nutrition1312015-01-012015-07-23
Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With Osteoporosis
Test group, Reference group - Postmenopausal Women With Osteoporosis
Phase 3CompletedAlvogen Korea2012011-12-012016-11-01

Conditions studied

Colic (1)  ·  Premature Birth (1)

Sponsors

Abbott Nutrition (2)  ·  Darma Inc. (2)  ·  Alvogen Korea (1)  ·  Centro Hospitalar de Lisboa Central (1)  ·  McMaster University (1)  ·  Shenzhen Salubris Pharmaceuticals Co., Ltd. (1)

Countries

United States (4)  ·  Canada (1)  ·  Portugal (1)  ·  South Korea (1)

Top investigators

Arrel Olano, MD (1)  ·  Daniel Virella, MD, MSc (1)  ·  Hongying Yang, MD (1)  ·  Janice Kajzer, MS, RD, LD (1)  ·  John Cairney, PhD (1)  ·  Judith Cullinane, MSN (1)  ·  Moo-il Kang, MD, PhD (1)  ·  Timberly Williams, PhD (1)

Results publications

PMID 30513944, PMID 36986263